Background illustration for clinical trials search

Pulmonary Hypertension Clinical Trials

Browse 652 pulmonary hypertension clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Functional Pulmonary Capillary Surface Area in BPA for CTEPH

for
Hypertension, Pulmonary, Pulmonary Thromboembolisms
Location: Montreal
Sponsor: Jewish General Hospital

Sex: All

Age: 18 - 70+

Code: NCT05719415

Recruiting

Right Ventricular Pacing in Pulmonary Arterial Hypertension

for
Pulmonary Artery Hypertension, Right Ventricular Dysfunction
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18 - 70+

Code: NCT04194632

Recruiting

PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation

for
Pulmonary Hypertension
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04901884

Recruiting

Ventilation and Perfusion Scan in Pulmonary Embolism Following Catheter Directed Thrombectomy Versus Anticoagulation Alone

for
Pulmonary Embolism, Pulmonary Hypertension,
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18+

Code: NCT05133713

Recruiting

Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease

for
COPD, Pulmonary Hypertension, Right Ventricular Dysfunction,
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 40+

Code: NCT05896579

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PAH Exercise Study

for
Pulmonary Arterial Hypertension (PAH), Exercise Therapy
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06941441

Phase 3, Recruiting

Endothelial Biomarkers of Systemic Sclerosis-associated Pulmonary Hypertension

for
Scleroderma, Pulmonary Hypertension
Location: New Orleans LA
Sponsor: Louisiana State University Health Sciences Center in New Orleans

Sex: All

Age: 18+

Code: NCT03459716

Recruiting

Sildenafil for Early Pulmonary Vascular Disease in Scleroderma

for
Scleroderma, Mildly Elevated Pulmonary Pressures
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT04797286

Phase 2, Recruiting

Identification of Heritable CTEPH

for
Chronic Thromboembolic Pulmonary Hypertension
Location: Murray UT
Sponsor: Intermountain Health Care, Inc.

Sex: All

Age: 18+

Code: NCT03579862

Recruiting

129Xe MRI Cardiopulmonary

for
Interstitial Lung Disease,
Location: Durham NC
Sponsor: Bastiaan Driehuys

Sex: All

Age: 18+

Code: NCT06038630

Phase 2, Recruiting

Feasibility of Semaglutide in Advanced Lung Disease

for
Obesity, Interstitial Lung Disease,
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18 - 70+

Code: NCT05746039

Phase 1, Phase 2, Recruiting

New Orleans Pulmonary Hypertension Biobank

for
Pulmonary Hypertension, Systemic Sclerosis,
Location: New Orleans LA
Sponsor: Louisiana State University Health Sciences Center in New Orleans

Sex: All

Age: 18+

Code: NCT03269630

Recruiting

Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients

for
Pulmonary Hypertension, Metal Poison
Location: Louisville KY
Sponsor: Jiapeng Huang

Sex: All

Age: 18+

Code: NCT04756076

Recruiting

A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension

for
Pulmonary Arterial Hypertension (PAH)
Location: Stanford CA
Sponsor: Joseph C. Wu

Sex: All

Age: 18 - 60

Code: NCT06872112

Phase 1, Recruiting

The Evaluation and Treatment of Elevated Left-Sided Filling Pressures by Balloon Inflation Within the IVC

for
Hypertension, Pulmonary, Heart Failure
Location: Mountain View CA
Sponsor: Cardioflow Technologies, LLC

Sex: All

Age: 18 - 70+

Code: NCT02984631

Recruiting

A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)

for
Congenital Diaphragmatic Hernia, Pulmonary Hypertension
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 0+

Code: NCT05201144

Phase 2, Recruiting

A Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension Transitioning From Oral Selexipag

for
Pulmonary Arterial Hypertension (PAH)
Location: Columbus GA
Sponsor: Liquidia Technologies, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07759804

Recruiting

An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension, Interstitial Lung Disease
Location: Naples FL, Bend OR
Sponsor: Insmed Incorporated

Sex: All

Age: 18+

Code: NCT07234032

Phase 3, Recruiting

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

for
Hypertension, Pulmonary, Lung Diseases, Interstitial
Location: Allen Park MI, Phoenix AZ, San Francisco CA
Sponsor: Tectonic Operating Company, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07473700

Phase 2, Recruiting

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

for
Pulmonary Hypertension, Interstitial Lung Disease
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT07561034

Recruiting

What is pulmonary hypertension?

Pulmonary hypertension is raised blood pressure in the arteries that carry blood from the heart to the lungs. Over time the right side of the heart has to pump harder against that pressure, and it can weaken and fail. Symptoms come on slowly: breathlessness with activity, tiredness, chest pressure, dizziness or fainting, and swelling in the ankles or belly. Because these signs look like asthma, heart disease, or simply being out of shape, the diagnosis is often delayed. It is suspected on an echocardiogram and confirmed by right heart catheterization, which measures the pressure directly.

Doctors sort pulmonary hypertension into five groups by cause, and the group decides the treatment. Group 1 is pulmonary arterial hypertension, or PAH, a rare disease of the small lung arteries themselves, which can be idiopathic, inherited, or linked to conditions such as scleroderma. Group 2, the most common, comes from left sided heart disease; group 3 from lung diseases such as COPD and pulmonary fibrosis; group 4 from old blood clots in the lungs, which surgery can sometimes cure; and group 5 from other or mixed causes. Most PAH medicines are approved only for group 1, which is why most drug trials enroll people with PAH.

Types of pulmonary hypertension clinical trials

Who can participate in pulmonary hypertension clinical trials?

Groups and functional class, and why they matter for trials

How to enroll in a pulmonary hypertension clinical trial